KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $121.2 billion.

  • Pfizer's Retained Earnings rose 7.52% to $121.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $121.2 billion, marking a year-over-year increase of 7.52%. This contributed to the annual value of $116.7 billion for FY2024, which is 137.55% down from last year.
  • Latest data reveals that Pfizer reported Retained Earnings of $121.2 billion as of Q3 2025, which was up 7.52% from $117.6 billion recorded in Q2 2025.
  • In the past 5 years, Pfizer's Retained Earnings ranged from a high of $131.1 billion in Q2 2023 and a low of $95.2 billion during Q2 2021
  • In the last 5 years, Pfizer's Retained Earnings had a median value of $118.4 billion in 2023 and averaged $116.4 billion.
  • Its Retained Earnings has fluctuated over the past 5 years, first surged by 2153.12% in 2022, then crashed by 947.23% in 2024.
  • Quarter analysis of 5 years shows Pfizer's Retained Earnings stood at $103.4 billion in 2021, then grew by 21.53% to $125.7 billion in 2022, then fell by 5.81% to $118.4 billion in 2023, then dropped by 1.38% to $116.7 billion in 2024, then grew by 3.79% to $121.2 billion in 2025.
  • Its last three reported values are $121.2 billion in Q3 2025, $117.6 billion for Q2 2025, and $119.6 billion during Q1 2025.